Target INR for TTK Chitra Mechanical Valve
For a TTK Chitra valve in the aortic position without additional risk factors, target an INR of 2.5 (range 2.0-3.0); for mitral position or aortic position with risk factors, target an INR of 3.0 (range 2.5-3.5).
Aortic Position
The TTK Chitra valve is a bileaflet mechanical valve, which falls under current-generation mechanical prostheses. According to the 2020 ACC/AHA guidelines, current-generation mechanical aortic valves without additional thromboembolic risk factors should be managed with an INR goal of 2.5 (range 2.0-3.0) 1. This target provides the optimal balance between preventing thromboembolism and minimizing bleeding risk, as moderate-intensity anticoagulation (INR 2.0-3.0) shows similar thromboembolic protection but significantly lower bleeding rates compared to high-intensity regimens (INR 3.0-4.5).
When to Increase the Target
Increase the INR goal to 3.0 (range 2.5-3.5) if any of these risk factors are present 1:
- Atrial fibrillation
- Previous thromboembolism
- Hypercoagulable state
- Severe left ventricular dysfunction
Mitral Position
For TTK Chitra valves in the mitral position, always target an INR of 3.0 (range 2.5-3.5) 1. Mitral mechanical valves carry inherently higher thromboembolic risk than aortic valves. The GELIA study demonstrated that lower INR ranges (2.0-3.5) in mitral valve patients were associated with decreased survival compared to higher target ranges (2.5-4.5) 1. The INR goal of 3.0 (range 2.5-3.5) represents a practical compromise that balances thrombotic protection with achievable therapeutic control—patients maintain this range approximately 75% of the time, compared to only 45% time-in-range with higher targets.
Important Caveats
- Specify a single INR target (e.g., 2.5 or 3.0) rather than just a range, as this reduces the likelihood of patients consistently running at the boundaries and improves overall anticoagulation stability 1
- Consider adding low-dose aspirin (75-100 mg daily) if there are additional indications for antiplatelet therapy, though this increases bleeding risk 1
- No bridging anticoagulation is needed for routine procedures in patients with mechanical aortic valves without risk factors; bridging should be considered for mitral valves or high-risk aortic valves 1
The TTK Chitra valve, being a modern bileaflet design, does not require the higher anticoagulation intensity needed for older-generation valves (ball-in-cage, tilting disc). While some research suggests even lower INR targets may be feasible with intensive self-monitoring 2, 3, the guideline-recommended targets remain the standard of care for routine clinical practice 1.